Roth Capital Lowers PT on LivePerson (LPSN) Following the Loss of AT&T
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Northland Capital Markets Lowers PT on LivePerson (LPSN) Following New Guidance
May 12, 2015 8:31 AM EDTmaintains an Outperform rating on LivePerson (NASDAQ: LPSN), but lowered the price target to $11.00 (from $16.00), based on FY16 revs. LPSN posted 1Q revenue slightly below estimates at $59.8M with EPS in line. FY15 revenue guidance decreased $21M. The new FY15 revenue guidance is $243 - $247mil (compared to the consensus of $264.3M estimate), and EPS of $0.10 - 0.15 (consensus of $0.28).
Northland Capital Markets analyst, Michael Latimore, commented on LPSN's quarter, saying, "Revs... More
Credit Suisse Downgrades LivePerson (LPSN) to Neutral
May 12, 2015 7:41 AM EDTCredit Suisse downgraded LivePerson (NASDAQ: LPSN) from Outperform to Neutral with a price target of $8.00 (from $19.00), saying losing AT&T worse than feared.
The firm cut estimates accordingly.
For an analyst ratings summary and ratings history on LivePerson... More
After-Hours Stock Movers 05/11: (WYY) (CALL) (PLAB) Higher; (NOR) (LPSN) (RAX) Lower (more...)
May 11, 2015 6:01 PM EDTNoranda Aluminum (NYSE: NOR) 19% LOWER; announced the commencement of a secondary public offering of 22,840,000 shares of the Companys common stock by certain funds affiliated with Apollo Global Management, LLC
NewLink Genetics Corporation (Nasdaq: NLNK) 17.4% LOWER; announced the continuation without any modification or sample size adjustment for its pivotal, Phase 3IMmunotherapy for Pancreatic RESectable cancer Study, called "IMPRESS," of algenpantucel-L for patients with surgically resected pancreatic cancer following the second planned interim data analysis.
LivePerson (NASDAQ:... More
LivePerson (LPSN) Misses Q1 EPS by 8c; Guides for Q2 Loss, Trims FY15 Outlook
May 11, 2015 4:39 PM EDTLivePerson (NASDAQ: LPSN) reported Q1 EPS of ($0.04), $0.08 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $59.8 million versus the consensus estimate of $60.8 million.
LivePerson signed a total of 147 deals in the quarter, which includes the addition of 30 new customers. Revenue per... More
